Detection of P16 and Hst Gene and Cell Proliferative Cycle in Human Pituitary Adenone and Study of Cell Cycle Regulation Mechanism
马文雄,惠国桢,吴士良,韦永新,陈桂林,张世明,周岱,杜子威
DOI: https://doi.org/10.3969/j.issn.1673-0399.2006.01.020
2006-01-01
Abstract:Objective To discuss the relation of changes in p16 and hst gene expression,and cell proliferative cycle to the oncogenesis,size,mode of invasive growth,ect of human pituitary adenoma.Methods Seventy cases of the tumor were analysed by RT-PRC and Western blot respectively.Forty eight cases of the tumor were surveyed by ABC immunohistochemistry methods.Flow cytometry(FCM) was used for detecting cell proliferative cycle in 40 cases.Results In tumors deletion of low level of p16 mRAN and p16 protein expression mostly was presented at a rate of 78.6%(55/70) and 84.3%(59/70),respectively.These figures showed high positive correlation(P0.01).In deletion or low level of p16 expression,the size of the tumor was 2.21±0.72 cm~3,obviously higher than that with positive expression in which it was 0.80±0.45 cm~3(P0.01).In invasive tumor,hst expression positivity rate was 55.6%(10/18).In the non-invasive tumor,the positivity rate of hst expression was 13.3%(4/30).There existed marked difference between them(P0.01).The size of the tumor with hst positive expression was 3.68±1.02 cm~3,overly greater than that with hst negative expression in which it was 2.16±1.12 cm~3(P0.05).Cell proliferative cycle analysis indicated that in DI,PI and S cycles of the invasive tumor the cell proportion was 1.38±0.62,11.35±1.26 and 4.00±1.96 respectively.This was obviously higher than that in the non-invasive tumor in which it was 1.17±0.31,7.28±0.08 and 1.95±1.02(P0.05).Conclusion In terms of histomorpholigy the tumor belongs to benign one,but it has different kinds of biological features.Changes of these features are correlated with the tumor's characters,such as size,mode of invasive growth,etc.These can provide an important hint for individualized diagnosis and treatment,as well as the assessment of the tumor prognosis.